Cécile Arellano

761 total citations
24 papers, 631 citations indexed

About

Cécile Arellano is a scholar working on Oncology, Pharmacology and Pharmacology. According to data from OpenAlex, Cécile Arellano has authored 24 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pharmacology and 5 papers in Pharmacology. Recurrent topics in Cécile Arellano's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Estrogen and related hormone effects (4 papers). Cécile Arellano is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Estrogen and related hormone effects (4 papers). Cécile Arellano collaborates with scholars based in France, Italy and Switzerland. Cécile Arellano's co-authors include John M. Woodley, Georges Houin, P Hermann, Alix Cloarec, Étienne Chatelut, Christelle Vachoux, Peggy Gandia, Florent Puisset, Thierry Lafont and Henri Roché and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Pharmaceutics and Cancer Letters.

In The Last Decade

Cécile Arellano

23 papers receiving 612 citations

Peers

Cécile Arellano

ONCOL

PHARM

PPCH

Xavier Boulenc France

Aki T. Heikkinen Finland

Chyung S. Cook United States

Weili Huang China

Katrijn Bogman Switzerland

Hilde Bohets Belgium

Glen Leesman United States

Noriko Katori Japan

Stephanie A. Sweetana United States

Masaki Ishigai United States

Xavier Boulenc France

Cécile Arellano

303 ×1.4

ONCOL

109 ×0.7

336 ×2.2

PHARM

198 ×1.4

94 ×1.3

PPCH

Citations per year, relative to Cécile Arellano Cécile Arellano (= 1×) peers Xavier Boulenc

Countries citing papers authored by Cécile Arellano

Since Specialization

Citations

This map shows the geographic impact of Cécile Arellano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Arellano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Arellano more than expected).

Fields of papers citing papers by Cécile Arellano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Arellano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Arellano. The network helps show where Cécile Arellano may publish in the future.

Co-authorship network of co-authors of Cécile Arellano

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Arellano. A scholar is included among the top collaborators of Cécile Arellano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Arellano. Cécile Arellano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laverrière, Marie‐Hélène, Maxime Henry, Cécile Arellano, et al.. (2024). Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine/Tipiracil) in digestive cancers by overexpressing thymidine phosphorylase. Cancer Letters. 606. 217307–217307. 2 indexed citations

Fillaudeau, Luc, et al.. (2024). A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions. European Journal of Pharmaceutics and Biopharmaceutics. 207. 114622–114622. 1 indexed citations

Arellano, Cécile, Christelle Vachoux, Christine Chevreau, et al.. (2022). Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury. Metabolites. 12(9). 852–852. 3 indexed citations

Puszkiel, Alicja, Cécile Arellano, Christelle Vachoux, et al.. (2019). Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study. Clinical Pharmacology & Therapeutics. 106(3). 585–595. 17 indexed citations

Puisset, Florent, et al.. (2018). Simultaneous monitoring of pazopanib and its metabolites by UPLC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 154. 373–383. 12 indexed citations

Bijani, Christian, et al.. (2018). Metalloporphyrin-Catalyzed Oxidation of Sunitinib and Pazopanib, Two Anticancer Tyrosine Kinase Inhibitors: Evidence for New Potentially Toxic Metabolites. Journal of Medicinal Chemistry. 61(17). 7849–7860. 28 indexed citations

Arellano, Cécile, et al.. (2014). An UPLC–MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers. Journal of Pharmaceutical and Biomedical Analysis. 100. 254–261. 17 indexed citations

Gandia, Peggy, et al.. (2012). Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?. Cancer Chemotherapy and Pharmacology. 71(2). 531–536. 25 indexed citations

Arellano, Cécile, et al.. (2012). Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC–MS/MS assay and ultrafiltration method. Journal of Chromatography B. 907. 94–100. 35 indexed citations

10.

Gandia, Peggy, Cécile Arellano, Isabelle Lochon, et al.. (2011). Unexpected High Levels of Vorinostat when Combined with Vinorelbine in Patients with Advanced Cancer. Current Clinical Pharmacology. 6(4). 274–279. 3 indexed citations

11.

Arellano, Cécile, et al.. (2011). In vivo Study of Percutaneous Absorption of 4-Chloroaniline Using Microdialysis in the Rat. Arzneimittelforschung. 50(11). 1033–1036.

12.

Bayındır, Zerrin Sezgin, et al.. (2010). The use of isolated enterocytes to study Phase I intestinal drug metabolism: validation with rat and pig intestine. Fundamental and Clinical Pharmacology. 25(1). 104–114. 3 indexed citations

13.

Arellano, Cécile, et al.. (2010). Quantification of topotecan by liquid chromatography–mass spectrometry (LC–MS). Application to intestinal transport using rat everted gut sacs. Journal of Chromatography B. 878(7-8). 645–652. 16 indexed citations

14.

Arellano, Cécile, Christelle Vachoux, John M. Woodley, et al.. (2008). Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter. Fundamental and Clinical Pharmacology. 22(2). 189–201. 15 indexed citations

15.

Arellano, Cécile, et al.. (2007). The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs.. PubMed. 10(1). 26–36. 30 indexed citations

16.

Arellano, Cécile, et al.. (2005). Validation of a liquid chromatography–mass spectrometry method to assess the metabolism of dextromethorphan in rat everted gut sacs. Journal of Chromatography B. 819(1). 105–113. 17 indexed citations

17.

Arellano, Cécile, et al.. (2005). Validation of a liquid chromatography–mass spectrometry method to assess the metabolism of bupropion in rat everted gut sacs. Journal of Chromatography B. 829(1-2). 50–55. 23 indexed citations

18.

Arellano, Cécile, et al.. (2004). Liquid chromatographic–mass spectrometric method to assess cytochrome P450-mediated metabolism of testosterone by rat everted gut sacs. Journal of Chromatography B. 807(2). 263–270. 13 indexed citations

19.

Woodley, John M., et al.. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. International Journal of Pharmaceutics. 278(1). 119–131. 253 indexed citations

20.

Arellano, Cécile, et al.. (2002). Development and evaluation of an HPLC urinalysis screening test for occupational exposure to 3,4- and 3,5-dichloroanilines. International Journal of Clinical Pharmacology and Therapeutics. 40(1). 41–46. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact